-- 
Israeli Stocks: Bioline, Ness Technologies, Tower, RadVision

-- B y   R o n i t   G o o d m a n
-- 
2011-04-04T14:39:16Z

-- http://www.bloomberg.com/news/2011-04-04/israeli-stocks-bioline-ness-technologies-tower-radvision.html
Israel ’s TA-25 Index was little
changed, adding less than 0.1 percent to 1,332.33 at the 4:30
p.m. close in Tel Aviv. Investors traded about 1.55 billion
shekels ($447 million) in shares and convertible securities.  The following stocks rose or fell today. Symbols are in
parentheses.  Bioline RX Ltd. (BLRX)   advanced the most since Sept. 6,
gaining 6.2 percent to 2.505 shekels. The biopharmaceutical
company said it received a U.S. patent for BL-1020 to treat
schizophrenia.  D.N.A. Biomedical Solutions Ltd. (DNA IT) increased the
most in a month, rising 3.8 percent to 0.271 shekel. A unit of
the Petach Tikvah, Israel-based company will start human trials
of an osteoporosis drug.  Ness Technologies Inc. (NSTC)   climbed to the highest
since Feb. 10, increasing 1.9 percent to 23.22 shekels.
Calcalist reported Vector Capital Corp., a San Francisco-based
venture capital firm, is in talks to buy the computer service
provider for $300 million. Calls made to Ness headquarters
weren’t answered.  Tower Semiconductors Ltd. (TSEM IT) rose to the highest
since Feb. 23, advancing 2.4 percent to 5.01 shekels. The maker
of semiconductor integrated circuits signed a non-binding
document to purchase Micron Technology Inc.’s manufacturing
facility in Nishiwaki City, Hyogo,  Japan , which would almost
double Tower’s manufacturing capacity.  RadVision Ltd. (RVSN)   plunged the most since October
2009, falling 13 percent to 36 shekels. The maker of video-
conferencing systems said lower than expected sales to Cisco
Systems Inc. would result in a larger-than-forecast first-
quarter loss.  To contact the reporter on this story:
Ronit Goodman in  Tel Aviv  at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  